Bo Huang

15.3k total citations · 7 hit papers
144 papers, 8.6k citations indexed

About

Bo Huang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Bo Huang has authored 144 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Immunology, 45 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in Bo Huang's work include Immune Cell Function and Interaction (28 papers), Immune cells in cancer (18 papers) and Immunotherapy and Immune Responses (16 papers). Bo Huang is often cited by papers focused on Immune Cell Function and Interaction (28 papers), Immune cells in cancer (18 papers) and Immunotherapy and Immune Responses (16 papers). Bo Huang collaborates with scholars based in China, United States and Canada. Bo Huang's co-authors include Ke Tang, Jonathan S. Bromberg, David T. Levy, Alice I. Sato, Shu‐Hsia Chen, Qingsheng Li, Celia M. Divino, Ping‐Ying Pan, Yi Zhang and Jingwei Ma and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Bo Huang

133 papers receiving 8.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

2006 1.1k citations Bo Huang et al. Cancer Research profile →
COVID-19: immunopathogenesis and Immunotherapeutics

2020 572 citations Bo Huang, Yi Zhang et al. profile →
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome

2020 423 citations Yuying Liu, Zhenfeng Wang et al. profile →
Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles

2021 271 citations Bo Huang et al. profile →
Lithium carbonate revitalizes tumor-reactive CD8+ T cells by shunting lactic acid into mitochondria

2024 71 citations Jingwei Ma, Keke Wei et al. Nature Immunology profile →
PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis

2024 59 citations Bo Huang, Yi Zhang et al. profile →
Ammonia-induced lysosomal and mitochondrial damage causes cell death of effector CD8+ T cells

2024 49 citations Huafeng Zhang, Jie Chen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bo Huang China	48	3.5k	2.9k	2.1k	1.1k	919	144	8.6k
Yu L. Lei United States	40	3.9k 1.1×	3.6k 1.2×	1.6k 0.7×	665 0.6×	496 0.5×	92	7.9k
Lorenzo Piemonti Italy	60	3.9k 1.1×	3.4k 1.2×	2.7k 1.3×	853 0.8×	708 0.8×	290	13.5k
Fangfang Zhou China	53	1.7k 0.5×	6.2k 2.1×	1.5k 0.7×	1.8k 1.7×	1.1k 1.2×	221	10.1k
Ming Li China	55	2.0k 0.6×	4.4k 1.5×	1.4k 0.7×	1.4k 1.3×	1.1k 1.2×	387	10.0k
Tingbo Liang China	49	1.8k 0.5×	3.0k 1.0×	2.6k 1.2×	1.5k 1.4×	632 0.7×	306	8.1k
Peter J. Nelson Germany	67	4.6k 1.3×	4.8k 1.6×	3.9k 1.8×	1.7k 1.6×	429 0.5×	252	13.8k
Wei Zhao China	47	2.8k 0.8×	4.4k 1.5×	1.1k 0.5×	1.3k 1.2×	781 0.8×	211	8.0k
Dermot Kelleher Ireland	56	2.4k 0.7×	2.4k 0.8×	1.5k 0.7×	624 0.6×	658 0.7×	228	9.9k
Ellen M. Gravallese United States	56	2.8k 0.8×	5.5k 1.9×	2.5k 1.2×	1.3k 1.2×	888 1.0×	142	12.2k
Sin‐Hyeog Im South Korea	50	2.7k 0.8×	3.4k 1.1×	1.0k 0.5×	617 0.6×	539 0.6×	181	8.5k

Countries citing papers authored by Bo Huang

Since Specialization

Citations

This map shows the geographic impact of Bo Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Huang more than expected).

Fields of papers citing papers by Bo Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Huang. The network helps show where Bo Huang may publish in the future.

Co-authorship network of co-authors of Bo Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Huang. A scholar is included among the top collaborators of Bo Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Huang. Bo Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Li, Dongxiao Wu, Yabo Zhou, et al.. (2025). Heterozygous human JAK2V617F activates AhR to drive essential thrombocythemia and promote thrombosis. The Journal of Experimental Medicine. 222(12).

Li, Xin, et al.. (2024). Uric acid in diabetic microvascular complications: Mechanisms and therapy. Journal of Diabetes and its Complications. 39(2). 108929–108929. 3 indexed citations

Zhang, Hu, et al.. (2024). Scutellarin alleviates tensile stress-induced proliferation and migration of venous smooth muscle cells via mediating the p38 MAPK pathway. Tissue and Cell. 87. 102300–102300. 1 indexed citations

Huang, Bo, et al.. (2023). Mechanism of TCF21 Downregulation Leading to Immunosuppression of Tumor-Associated Macrophages in Non-Small Cell Lung Cancer. Pharmaceutics. 15(9). 2295–2295. 9 indexed citations

Lv, Xiaoxi, Shanshan Liu, Chang Liu, et al.. (2023). TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2. Acta Pharmaceutica Sinica B. 13(4). 1631–1647. 13 indexed citations

Zhou, Li, Dongxiao Wu, Yabo Zhou, et al.. (2023). Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR–RUNX1. Nature Immunology. 24(12). 2042–2052. 20 indexed citations

Tang, Ke, Liyan Zhu, Jie Chen, et al.. (2021). Hypoxia Promotes Breast Cancer Cell Growth by Activating a Glycogen Metabolic Program. Cancer Research. 81(19). 4949–4963. 75 indexed citations

Liu, Yuying, Tianzhen Zhang, Haizeng Zhang, et al.. (2020). Cell Softness Prevents Cytolytic T-cell Killing of Tumor-Repopulating Cells. Cancer Research. 81(2). 476–488. 88 indexed citations

Zhang, Huafeng, Jingwei Ma, Ke Tang, & Bo Huang. (2020). Beyond energy storage: roles of glycogen metabolism in health and disease. FEBS Journal. 288(12). 3772–3783. 43 indexed citations

10.

Wang, Lijing, et al.. (2020). Risk Stratification Based on Metastatic Pelvic Lymph Node Status in Stage IIIC1p Cervical Cancer. SHILAP Revista de lepidopterología.

11.

Shen, Shiqian, Grewo Lim, Zerong You, et al.. (2017). Gut microbiota is critical for the induction of chemotherapy-induced pain. Nature Neuroscience. 20(9). 1213–1216. 218 indexed citations

12.

Cui, Bing, Xuetao Cao, Weiping Zou, et al.. (2017). Regulation of immune-related diseases by multiple factors of chromatin, exosomes, microparticles, vaccines, oxidative stress, dormancy, protein quality control, inflammation and microenvironment: a meeting report of 2017 International Workshop of the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine on Tumor Immunology. Acta Pharmaceutica Sinica B. 7(4). 532–540. 3 indexed citations

13.

Li, Ran, Yanchun Li, Huafeng Zhang, et al.. (2016). Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy. Biomaterials. 89. 56–66. 85 indexed citations

14.

Xin, Xin, Zhen Liu, Hao Li, et al.. (2016). Propofol inhibits T-helper cell type-2 differentiation by inducing apoptosis via activating gamma-aminobutyric acid receptor. Journal of Surgical Research. 206(2). 442–450. 10 indexed citations

15.

Liu, Jing, Youhua Tan, Huafeng Zhang, et al.. (2012). Soft fibrin gels promote selection and growth of tumorigenic cells. Nature Materials. 11(8). 734–741. 384 indexed citations

16.

Ye, Zhijian, Qiong Zhou, Mingli Yuan, et al.. (2011). Differentiation and Recruitment of IL-22–Producing Helper T Cells Stimulated by Pleural Mesothelial Cells in Tuberculous Pleurisy. American Journal of Respiratory and Critical Care Medicine. 185(6). 660–669. 47 indexed citations

17.

Liu, Jing, Yi Zhang, Jie Zhao, et al.. (2011). Mast cell: insight into remodeling a tumor microenvironment. Cancer and Metastasis Reviews. 30(2). 177–184. 65 indexed citations

18.

Zhao, Jie, Yuchun Cao, Lei Zhang, et al.. (2010). Selective Depletion of CD4+CD25+Foxp3+ Regulatory T Cells by Low-Dose Cyclophosphamide Is Explained by Reduced Intracellular ATP Levels. Cancer Research. 70(12). 4850–4858. 175 indexed citations

19.

Huang, Bo, Lei Zhang, Guimei Zhang, et al.. (2008). SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood. 112(4). 1269–1279. 259 indexed citations

20.

Song, Chuanwang, Liqiong Luo, Lei Zhang, et al.. (2008). IL-17-Producing Alveolar Macrophages Mediate Allergic Lung Inflammation Related to Asthma. The Journal of Immunology. 181(9). 6117–6124. 245 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact